ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

11,370

Employees11,370

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

11,370

Employees11,370

RMD Key Statistics

Market cap

34.66B

Market cap34.66B

Price-Earnings ratio

23.04

Price-Earnings ratio23.04

Dividend yield

1.00%

Dividend yield1.00%

Average volume

1.44M

Average volume1.44M

High today

$241.03

High today$241.03

Low today

$235.52

Low today$235.52

Open price

$235.52

Open price$235.52

Volume

1.37M

Volume1.37M

52 Week high

$284.87

52 Week high$284.87

52 Week low

$180.27

52 Week low$180.27

Stock Snapshot

The current ResMed(RMD) stock price is $240.33, with a market capitalization of 34.66B. The stock trades at a price-to-earnings (P/E) ratio of 23.04 and offers a dividend yield of 1.00%.

As of 2026-08-31, ResMed(RMD) stock has fluctuated between $235.52 and $241.03. The current price stands at $240.33, placing the stock +2.0% above today's low and -0.3% off the high.

ResMed(RMD) shares are trading with a volume of 1.37M, against a daily average of 1.44M.

During the past year, ResMed(RMD) stock moved between $180.27 at its lowest and $284.87 at its peak.

RMD News

MarketWatch 2d

ResMed Inc. stock rises Friday, outperforms market - MarketWatch

...

Simply Wall St 5d

Is ResMed’s NASCAR Push Revealing a Deeper Shift in Governance and Brand Strategy?

In August 2026, ResMed announced that Carol Burt will become Lead Director in November 2026, the company dismissed KPMG as its auditor and appointed Pricewaterh...

TipRanks 6d

ResMed Tests Wearable PAP Device, Signaling Next Wave of Sleep Apnea Innovation

Resmed Inc (RMD) announced an update on their ongoing clinical study. ResMed Inc.’s new study, “Evaluation of the Feasibility, Usability and Short-Term Tolerab...

Analyst ratings

59%

of 29 ratings

Buy

58.6%

Hold

34.5%

Sell

6.9%

More RMD News

Simply Wall St 7d

Is ResMed Undervalued As Board And Auditor Changes Draw Investor Attention?

Advertisement Why ResMed Stock Is Back in Focus After Board and Auditor Changes ResMed (RMD) is drawing attention after announcing two governance moves. Carol...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.